Filter Results:
(3,188)
Show Results For
- All HBS Web
(3,188)
- People (7)
- News (425)
- Research (2,385)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,961)
Show Results For
- All HBS Web
(3,188)
- People (7)
- News (425)
- Research (2,385)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,961)
- September 2020 (Revised May 2021)
- Case
The Indian Premier League, 2020
By: John R. Wells and Benjamin Weinstock
Since its founding in 2008, the Indian Premier League (IPL), India’s eight-week Twenty20 (T20) cricket competition, had become one of the most popular and lucrative sporting leagues in the world. In 2019, the IPL attracted 462 million TV viewers and 300 million digital... View Details
Keywords: Sports; Organizational Structure; Marketing; Health Pandemics; Organizational Change and Adaptation; Growth and Development Strategy; Sports Industry; India
Wells, John R., and Benjamin Weinstock. "The Indian Premier League, 2020." Harvard Business School Case 721-362, September 2020. (Revised May 2021.)
- 10 Sep 2012
- HBS Case
HBS Cases: Branding Yoga
Women's Health and the Huffington Post. In 2008, after opening her own studio, Strala Yoga, the popular doctor and self-help author Deepak Chopra hired Stiles as his personal yoga instructor, a huge endorsement. Stiles created controversy... View Details
- November 1991 (Revised April 1994)
- Case
Nucleon, Inc.
By: Gary P. Pisano
Nucleon is a small biotechnology company whose first potential product is about to enter clinical testing. Before Nucleon can begin clinical trials, however, its management must decide how and where to manufacture the product. Three options are being contemplated: 1)... View Details
Keywords: Factories, Labs, and Plants; Entrepreneurship; Health Testing and Trials; Rights; Product Development; Production; Partners and Partnerships; Research and Development; Biotechnology Industry
Pisano, Gary P. "Nucleon, Inc." Harvard Business School Case 692-041, November 1991. (Revised April 1994.)
- May 2010 (Revised May 2011)
- Case
Kent Thiry: "Mayor" of DaVita
By: William W. George and Natalie Kindred
Kent Thiry, CEO of dialysis provider DaVita, is considering how to integrate employees from recently acquired Gambro Healthcare without damaging DaVita's robust, unconventional internal culture. When Thiry joined DaVita in 1999, breaking an important promise to his... View Details
Keywords: Mergers and Acquisitions; Experience and Expertise; Employee Relationship Management; Leadership Style; Organizational Change and Adaptation; Organizational Culture; Personal Development and Career; Integration; Health Industry
George, William W., and Natalie Kindred. Kent Thiry: "Mayor" of DaVita. Harvard Business School Case 410-065, May 2010. (Revised May 2011.)
- January 2, 2020
- Article
Changes in Quality of Care After Hospital Mergers and Acquisitions
By: Nancy Dean Beaulieu, Leemore S. Dafny, B. E. Landon, Jesse Dalton, Ifedayo Kuye and J. Michael McWilliams
Background: The hospital industry has consolidated substantially during the past two decades and at an accelerated pace since 2010. Multiple studies have shown that hospital mergers have led to higher prices for commercially insured patients, but research about effects... View Details
Beaulieu, Nancy Dean, Leemore S. Dafny, B. E. Landon, Jesse Dalton, Ifedayo Kuye, and J. Michael McWilliams. "Changes in Quality of Care After Hospital Mergers and Acquisitions." New England Journal of Medicine 382, no. 1 (January 2, 2020): 51–59.
- November 2022 (Revised April 2024)
- Case
Martine Rothblatt and United Therapeutics: A Series of Implausible Dreams
By: Debora L. Spar and Julia M. Comeau
In 1990, satellite expert and Sirius XM founder Martine Rothblatt was determined to save the life of her seven-year-old daughter, Jenesis, who was diagnosed with a terminal illness called Pulmonary Arterial Hypertension (PAH). At the time, there was little medication... View Details
Keywords: Pharmaceutical Companies; Technological And Scientific Innovation; Organ Donation; Health Care and Treatment; Health Disorders; Innovation and Invention; Pharmaceutical Industry; Pharmaceutical Industry; United States; District of Columbia
Spar, Debora L., and Julia M. Comeau. "Martine Rothblatt and United Therapeutics: A Series of Implausible Dreams." Harvard Business School Case 323-039, November 2022. (Revised April 2024.)
- 04 Oct 2011
- First Look
First Look: October 4
knowing "who we are" might depend in part on repeatedly remembering to forget "who we were not." The Enabling Role of Social Position in Diverging from the Institutional Status Quo: Evidence from the U.K. National View Details
Keywords: Sean Silverthorne
- 03 Apr 2012
- First Look
First Look: April 3
leadership development programs for residents. The authors first present a definition of clinical leadership and highlight evidence that effective frontline clinical leadership improves both clinical outcomes and satisfaction for patients and providers. The authors... View Details
Keywords: Carmen Nobel
- 12 Nov 2019
- Research & Ideas
Corporate Innovation Increasingly Benefits from Government Research
sponsored by government agencies, such as the National Science Foundation (NSF) or the National Institutes of Health (NIH). “Previously, it was possible to figure out what patents came directly out of government research labs,” Yao says.... View Details
Keywords: by Michael Blanding
- 12 Nov 2021
- News
Alumni Business Leaders on Confronting the Climate Change Challenge
health justice, and social justice. Ultimately, we need to create a new decision-making paradigm, where our business strategies and choices fully consider the short- and long-term impacts we have on the environment, on communities, and on... View Details
- 02 Aug 2016
- First Look
August 2, 2016
The Unintended Consequences of the Zero Lower Bound Policy By: Di Maggio, Marco, and Marcin Kacperczyk Abstract—We study the impact of the zero lower bound interest rate policy on the industrial organization of the U.S. money fund... View Details
Keywords: Sean Silverthorne
- Web
Helping and harnessing business to address society’s greatest challenges. | Institute for Business in Global Society
historical perspective— innovative, disruptive, secular— continues to shape teaching, research, and multi-faculty projects at HBS today. Entrepreneurship Initiative The Arthur Rock Center for Entrepreneurship is a vital resource to HBS students and a champion for... View Details
- 01 Dec 2022
- News
Full Court Press
as a platform to not only improve the health and wellness of one of the world’s youngest and fastest growing populations but also to create a whole new industry around the business of sports,” says Tatum.... View Details
Keywords: Dan Morrell
- February 2022 (Revised March 2022)
- Case
Hertz in Bankruptcy: A Wild Ride in Pandemic Times
Hertz filed for Chapter 11 bankruptcy in response to asset-backed securities (ABS) obligations and the COVID-19 pandemic. Enthusiastic Robinhood investors and shrewd negotiating tactics helped Hertz stabilize. Roughly nine months into the bankruptcy, Hertz received... View Details
Keywords: Bankruptcy Reorganization; COVID-19 Pandemic; Insolvency and Bankruptcy; Health Pandemics; Valuation; Capital Structure; Negotiation; Private Equity; Travel Industry; United States
Antill, Samuel, Stuart Gilson, and Kristin Mugford. "Hertz in Bankruptcy: A Wild Ride in Pandemic Times." Harvard Business School Case 222-064, February 2022. (Revised March 2022.)
- 22 Feb 2024
- News
GCC Crossroads Aims for a Bright Future; Seattle Alumni Talk Leadership in Tech; Italy Preps for European Alumni Summit
Clubs News Clubs News Crossroads Forum Explores Future of Gulf Region More than 1,300 public and private leaders convened in Riyadh, Saudi Arabia on January 30 and 31 for the Crossroads GCC Future Impact Forum, co-hosted by the HBS Club of the Gulf Cooperation Council... View Details
Keywords: Margie Kelley
- Spring 2012
- Article
Sustainability at Dow Chemical
By: Robert G. Eccles, Kathleen M. Perkins and Mark Weick
Dow Chemical Company, which was founded in 1894, is now the second-largest chemical company in the world. From the outset, the company has been committed to high-technology research and commercial innovation in chemistry, advanced materials, and agro-sciences. But if... View Details
Keywords: Value Creation; Corporate Strategy; Chemicals; Environmental Sustainability; Innovation and Invention; Chemical Industry
Eccles, Robert G., Kathleen M. Perkins, and Mark Weick. "Sustainability at Dow Chemical." Journal of Applied Corporate Finance 24, no. 2 (Spring 2012): 38–44.
- Web
Harvard Business School
Stuart Taylor is the chief executive officer of the Taylor Group. Since 2002, the Taylor Group has invested in ten companies in industries including financial services, technology, and health care. Prior to... View Details
- 01 Nov 2022
- What Do You Think?
Why Aren’t Business Leaders More Vocal About Immigration Policy?
high tech. My colleague, William Kerr, has written extensively about the efforts through various avenues to ensure an adequate flow of tech talent into the country. But leaders in other industries seem to have been reluctant to influence... View Details
Keywords: by James Heskett
- Web
2024 Reunion Presentations - Alumni
now, and how will they use their power? Will we see bigger bets on likely blockbusters, more intense competition in areas such as streaming and esports, and more industry consolidation? Drawing on dozens of recent case studies, Professor... View Details
- February 2024
- Article
Representation and Extrapolation: Evidence from Clinical Trials
By: Marcella Alsan, Maya Durvasula, Harsh Gupta, Joshua Schwartzstein and Heidi L. Williams
This article examines the consequences and causes of low enrollment of Black patients in clinical
trials. We develop a simple model of similarity-based extrapolation that predicts that evidence is
more relevant for decision-making by physicians and patients when it... View Details
Keywords: Representation; Racial Disparity; Health Testing and Trials; Race; Equality and Inequality; Innovation and Invention; Pharmaceutical Industry
Alsan, Marcella, Maya Durvasula, Harsh Gupta, Joshua Schwartzstein, and Heidi L. Williams. "Representation and Extrapolation: Evidence from Clinical Trials." Quarterly Journal of Economics 139, no. 1 (February 2024): 575–635.